{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:27Z","timestamp":1793946507325,"version":"4.8.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105496","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:27:25Z","timestamp":1784388445000},"page":"105496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic analysis and clinical translation strategies of m6A erasers in the metabolism-immunity axis of hepatocellular carcinoma"],"prefix":"10.1016","volume":"226","author":[{"given":"Qin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105496_bib1","article-title":"Optimizing wound healing with antibacterial metal oxide nanoparticles: a comparative analysis of efficacy and biological mechanisms","volume":"105","author":"Abbas","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/biom14080932","article-title":"The RNA demethylases ALKBH5 and FTO regulate the translation of ATF4 mRNA in Sorafenib-treated hepatocarcinoma cells","volume":"14","author":"Adjibade","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105496_bib3","doi-asserted-by":"crossref","DOI":"10.1063\/5.0092330","article-title":"Nanoformulation of intelligence polymeric nanocarrier for resveratrol targeted delivery and study its cytotoxic, apoptotic, and genetics effects in epidermoid carcinoma therapy","volume":"2437","author":"Alnasraui","year":"2022","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.critrevonc.2026.105496_bib4","first-page":"285","article-title":"Riboflavin metabolism: role in mitochondrial function","volume":"4","author":"Balasubramaniam","year":"2020","journal-title":"J. Transl. Genet. Genom."},{"key":"10.1016\/j.critrevonc.2026.105496_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/cancers15020348","article-title":"Unraveling the synergy between atezolizumab and bevacizumab for the treatment of hepatocellular carcinoma","volume":"15","author":"Brackenier","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105496_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-022-01704-8","article-title":"m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion","volume":"22","author":"Cao","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105496_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.17305\/bb.2024.10247","article-title":"ALKBH5 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by regulating TTI1 expression","volume":"24","author":"Chang","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.critrevonc.2026.105496_bib8","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1038\/s41467-025-64572-y","article-title":"FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinoma","volume":"16","author":"Chao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105496_bib9","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1021\/acs.jmedchem.3c00302","article-title":"Recent advances in pro-PROTAC development to address on-target off-tumor toxicity","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105496_bib10","doi-asserted-by":"crossref","unstructured":"Chen, A., Zhang, V.X., Zhang, Q., Sze, K.M.-F., Tian, L., Huang, H., Wang, X., Lee, E., Lu, J., Lyu, X., Lee, M.-F.J., Wong, C.M., Ho, D.W.-H., Ng, I.O.-L., 2025. Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma. https:\/\/doi.org\/10.1136\/gutjnl-2024-331903.","DOI":"10.1136\/gutjnl-2024-331903"},{"key":"10.1016\/j.critrevonc.2026.105496_bib11","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.7150\/ijbs.120058","article-title":"Unveiling the dynamics and therapeutic potential of m6A methyltransferases and demethylases in liver diseases","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.immuni.2017.07.015","article-title":"CCCTC-binding factor translates interleukin 2- and \u03b1-ketoglutarate-sensitive metabolic changes in T cells into context-dependent gene programs","volume":"47","author":"Chisolm","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105496_bib13","series-title":"Resistance to Molecular Therapies for Hepatocellular Carcinoma","first-page":"1","article-title":"Tumor heterogeneity and resistance to targeted therapies in hepatocellular carcinoma","author":"Craig","year":"2017"},{"key":"10.1016\/j.critrevonc.2026.105496_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107720","article-title":"Cold atmospheric plasma control metabolic syndromes via targeting fat mass and obesity-associated protein","volume":"215","author":"Dai","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1507171","article-title":"Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression","volume":"13","author":"Fan","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/biom15020157","article-title":"M6A demethylase ALKBH5 in human diseases: from structure to mechanisms","volume":"15","author":"Fang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105496_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-024-01546-5","article-title":"Small molecule inhibitors targeting m6A regulators","volume":"17","author":"Feng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13578-024-01286-6","article-title":"Insights into the m6A demethylases FTO and ALKBH5: structural, biological function, and inhibitor development","volume":"14","author":"Gao","year":"2024","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib19","article-title":"RNA m6A modification in cancers: molecular mechanisms and potential clinical applications","volume":"1","author":"Gu","year":"2020","journal-title":"Innovation"},{"key":"10.1016\/j.critrevonc.2026.105496_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in HCC","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12668-025-02144-6","article-title":"Superparamagnetic Iron Oxide Nanoparticles: Multifunctional Targeted Platforms for Cancer Detection and Combination Therapy","volume":"15","author":"Haider","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.critrevonc.2026.105496_bib22","doi-asserted-by":"crossref","unstructured":"Heinrich, B., Cubero, F.J., 2025. FTO\/m6A\/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment? https:\/\/doi.org\/10.1136\/gutjnl-2024-332934.","DOI":"10.1136\/gutjnl-2024-332934"},{"key":"10.1016\/j.critrevonc.2026.105496_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/0113892002387502250714112923","article-title":"m6A Modified-CYP1B1 Promotes HCC Cell Proliferation by Inhibiting Ferroptosis","volume":"26","author":"Huang","year":"2025","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.critrevonc.2026.105496_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105496_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tig.2019.10.011","article-title":"The biogenesis and precise control of RNA m6A methylation","volume":"36","author":"Huang","year":"2020","journal-title":"Trends Genet. TIG"},{"key":"10.1016\/j.critrevonc.2026.105496_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103645","article-title":"Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: a retrospective cohort study","volume":"77","author":"Ivanics","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.critrevonc.2026.105496_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1186\/s12967-025-07155-1","article-title":"Hypoxia-mediated m6A modulation in hepatocellular carcinoma: a comprehensive review","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105496_bib30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/JHC.S318070","article-title":"Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma \u2013 The Changing Tides","volume":"8","author":"Khan","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2026.105496_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000528272","article-title":"IMbrave150: efficacy and safety of Atezolizumab plus Bevacizumab versus Sorafenib in patients with barcelona clinic liver Cancer Stage B Unresectable Hepatocellular Carcinoma: an exploratory analysis of the phase III study","volume":"12","author":"Kudo","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.critrevonc.2026.105496_bib32","article-title":"m6A-mediated TMCO3 promotes hepatocellular carcinoma progression by facilitating the membrane translocation and activation of AKT","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105496_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jare.2025.01.019","article-title":"Hypoxia-induced degradation of FTO promotes apoptosis by unmasking RACK1-mediated activation of MTK1-JNK1\/2 pathway","volume":"77","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib35","article-title":"New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12967-025-06314-8","article-title":"MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105496_bib37","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti\u2013PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib38","first-page":"6084","article-title":"m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12935-024-03559-z","article-title":"Ferroptosis: insight into the treatment of hepatocellular carcinoma","volume":"24","author":"Liao","year":"2024","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105496_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2016.09.086","article-title":"Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity","volume":"479","author":"Lim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105496_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.critrevonc.2026.105496_bib42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105496_bib43","article-title":"m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib44","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.apsb.2024.07.016","article-title":"Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105496_bib45","article-title":"The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116365","article-title":"N6-methyladenosine (m6A) modification in hepatocellular carcinoma","volume":"173","author":"Ma","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105496_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1541-7786.MCR-23-0720","article-title":"Hepatitis B virus\u2013mediated m6A demethylation increases hepatocellular carcinoma stemness and immune escape","volume":"22","author":"Meng","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib48","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/bph.15014","article-title":"Proteolysis-targeting chimeras in drug development: a safety perspective","volume":"177","author":"Moreau","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105496_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1611007","article-title":"Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms","volume":"15","author":"Ou","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.apsb.2023.09.003","article-title":"Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105496_bib52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-021-08449-5","article-title":"A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis","volume":"21","author":"Qu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105496_bib53","volume":"37","author":"Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105496_bib54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15476286.2021.2016203","article-title":"The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells","volume":"19","author":"Relier","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.20892\/j.issn.2095-3941.2020.0402","article-title":"The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics","volume":"17","author":"Shen","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105496_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1772310","article-title":"Recent advances in m6A RNA modification in hepatocellular carcinoma: from mechanisms to therapeutic potential","volume":"13","author":"Shi","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib57","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.2147\/CMAR.S286275","article-title":"METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR\/PI3K\/AKT Signaling Pathway in an m6A-Dependent Manner","volume":"12","author":"Shi","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib58","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105496_bib59","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1007\/s11468-024-02469-0","article-title":"Laser-fabricated metal oxide core\u2013shell nanoparticles for biomedical applications: a mini review","volume":"20","author":"Talib","year":"2025","journal-title":"Plasmonics"},{"key":"10.1016\/j.critrevonc.2026.105496_bib60","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.apsb.2022.01.016","article-title":"Using proteomimetics to switch angiogenic signaling","volume":"12","author":"Teng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105496_bib61","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.3390\/cancers14164036","article-title":"Role of exosomes in immunotherapy of hepatocellular carcinoma","volume":"14","author":"Tian","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105496_bib62","article-title":"The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome","author":"Tsukuda","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.critrevonc.2026.105496_bib63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jcm6050052","article-title":"Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases","volume":"6","author":"Udhayabanu","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105496_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114669","article-title":"The emerging importance role of m6A modification in liver disease","volume":"162","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105496_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-022-00370-2","article-title":"ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner","volume":"12","author":"Wang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12935-022-02452-x","article-title":"Dynamic regulation and functions of mRNA m6A modification","volume":"22","author":"Wang","year":"2022","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105496_bib67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential m6A, m6Am, and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.critrevonc.2026.105496_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150260","article-title":"Roles of m6A erasers FTO and ALKBH5 in drug resistance of hepatocellular carcinoma: mechanisms and clinical implications","volume":"1006","author":"Wen","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105496_bib69","article-title":"The Role of Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) in Tumors and Other Diseases","volume":"4","author":"Wu","year":"2025","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10735-025-10557-6","article-title":"The FTO-YTHDF2 axis drives immune evasion and tumor progression in hepatocellular carcinoma via m6A-dependent FLAD1 regulation","volume":"56","author":"Xu","year":"2025","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1558468","article-title":"Advances in the mechanism of small extracellular vesicles promoting the development of hepatocellular carcinoma through multi-network fusion","volume":"16","author":"Yuan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib73","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s13577-024-01044-3","article-title":"The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma","volume":"37","author":"Zang","year":"2024","journal-title":"Hum. Cell"},{"key":"10.1016\/j.critrevonc.2026.105496_bib74","first-page":"385","article-title":"FTO promotes hepatocellular carcinoma progression by mediating m6A modification of BUB1 and targeting TGF-\u03b2R1 to activate the TGF-\u03b2 signaling pathway","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib75","first-page":"2989","article-title":"RNA methylation regulators contribute to poor prognosis of hepatocellular carcinoma associated with the suppression of bile acid metabolism: a multi-omics analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105496_bib76","first-page":"409","article-title":"PROTACs Targeting Epigenetic Proteins","volume":"2","author":"Zhang","year":"2023","journal-title":"Acta Mater. Med."},{"key":"10.1016\/j.critrevonc.2026.105496_bib77","article-title":"An m6A-related lncRNA signature predicts the prognosis of hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib78","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41418-025-01453-3","article-title":"Protein kinase a regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5","volume":"32","author":"Zhao","year":"2025","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.critrevonc.2026.105496_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s43657-021-00043-w","article-title":"Emerging regulatory mechanisms of n6-methyladenosine modification in cancer metastasis","volume":"3","author":"Zhao","year":"2022","journal-title":"Phenomics"},{"key":"10.1016\/j.critrevonc.2026.105496_bib80","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12935-025-03923-7","article-title":"Targeting m6A methylation for early diagnosis and precision medicine in hepatocellular carcinoma","volume":"25","author":"Zheng","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105496_bib81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13578-025-01395-w","article-title":"FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion","volume":"15","author":"Zhou","year":"2025","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105496_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680101","article-title":"Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105496_bib83","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/s41467-025-58309-0","article-title":"FTO suppresses DNA repair by inhibiting PARP1","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:38:09Z","timestamp":1793943489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":83,"alternative-id":["S1040842826003835"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105496","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic analysis and clinical translation strategies of m6A erasers in the metabolism-immunity axis of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105496"}}